From Our Writers

In a ruling last month, Brazil’s Supreme Court federally legalized the cultivation, manufacturing, and distribution of hemp-derived medicinal products.

The Yale Center for the Science of Cannabis and Cannabinoids is awarding over $600,000 in grants to Yale School of Medicine researchers investigating the impact of cannabis and cannabinoids on neurodevelopment and mental health.

A study published this month that followed more than 5,000 men over 44 years found that long-term cannabis use is not associated with IQ decline in older adults.

A Minnesota judge blocked the state’s cannabis social equity license lottery this week in light of several lawsuits filed by applicants whose applications were denied last week.

Two lawsuits filed against the Minnesota Office of Cannabis Management aim to delay the state’s social equity licensing lottery after the agency denied about two-thirds of the social equity applicants.

In a letter last week, sixty-six members of Congress asked President Joe Biden (D) to use his clemency powers to “address longstanding injustices” in the U.S. legal system during the final months of his presidency.

Kentucky is set to open medical cannabis patient certifications on December 1 in preparation for launching the state’s medical cannabis program next year.

A Nebraska judge last week dropped all charges against a notary public caught up in an ongoing legal challenge against the medical cannabis ballot initiatives approved by voters earlier this month.

The state of Michigan has ended its industrial hemp program and turned oversight of its hemp farmers over to the feds with the USDA.

A new draft of the Farm Bill includes language aimed at closing intoxicating hemp loopholes, but stops short of setting per-serving or per-container limits for hemp-derived THC.

The FDA has approved a previously stalled clinical trial investigating whether smoking medical cannabis can help to treat post-traumatic stress disorder (PTSD) among combat veterans.

Texas Attorney General Ken Paxton this week filed a lawsuit against the city of Dallas over the city’s new, voter-backed cannabis decriminalization policy.

Minnesota officials this week denied about 1,200 cannabis social equity applicants, two-thirds of those who applied, for issues ranging from inadequate paperwork to “flooding” the application pool in an attempt to improve the odds of receiving a license.

The average price of cannabis flower in Michigan dropped to $74 per ounce in October, down almost $20 from September.

Data shows that millennials made about 45% of the cannabis industry’s pre-roll purchases from 2023 to mid-2024.

Massachusetts cannabis regulators last week issued the state’s first cannabis research license to a facility operated by Curaleaf Processing, a subsidiary of Curaleaf Holdings.

Georgia medical cannabis operators are opening additional dispensaries after the state program’s total patient count exceeded 25,000, a threshold set by the state’s medical cannabis policy.

An appellate judges panel in Missouri recently ruled that local governments cannot stack cannabis sales taxes, overturning a lower court’s decision from May.

Nearly one-third (32%) of medical cannabis patients cite chronic pain as their primary condition for medical cannabis use, with anxiety the second most common (26.8%) followed by insomnia (18.5%).

The Cannabis Research Institute, a collaboration between the University of Illinois and Discovery Partners Institute backed by the State of Illinois and the City of Chicago, officially launched last week.

USDA officials last week delayed the enforcement of a rule requiring consumer hemp products to be tested by labs registered with the DEA; it’s the third year in a row that officials have delayed enforcing the rule.